Pharmacology of Recombinant Adeno-associated Virus Production
Recombinant adeno-associated viral (rAAV) vectors have been used in more than 150 clinical trials with a good safety profile and significant clinical benefit in many genetic diseases. In addition, due to their ability to infect non-dividing and dividing cells and to serve as efficient substrate for...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2018-03-01
|
| Serie: | Molecular Therapy: Methods & Clinical Development |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2329050118300032 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|